External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CHDI 2025

-
Coming soon
05:00 PM
Duration 20mins Palm Springs
Towards disease modifying treatments in HD: An update from Roche
Peter McColgan

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:00 PM
Duration 180mins California, US
Development of a long-read phasing assay for allele-specific patient inclusion for Roche HTT SNP ASO program
Anna Rautanen

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:00 PM
Duration 25mins Palm Springs
Allele-selective lowering in HD: From bench to bedside
Peter McColgan

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar